Board MeetingBEACONPHAR
BEACONPHAR Board to Review Q3 Results for FY 2025–26 on 27 April 2026
Announcement summary
- What happened
- BEACONPHAR will hold a board meeting on 27 April 2026 at 3:00 PM to review unaudited financial statements for Q3 of FY 2025–26.
- Meeting date
- 27 April 2026
- Meeting time
- 3:00 PM
- Purpose
- consider audited financial statements
- Financial period
- Q3
- Financial year
- FY 2025–26
- Company
- Beacon Pharmaceuticals PLC
- Announcement published
Original announcement
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 27, 2026 at 3:00 pm to consider, among others, Un-Audited Financial Statements for the Third Quarter (Q3) period ended March 31, 2026.
বাংলা অনুবাদ — BullBD
This is a BullBD translation of the published corporate disclosure.
ঢাকা স্টক এক্সচেঞ্জ (লিস্টিং) রেগুলেশন, 2015 এর রেগুলেশন 16(1) অনুসারে, কোম্পানি জানিয়েছে যে 31 মার্চ, 2026 তারিখে সমাপ্ত তৃতীয় ত্রৈমাসিক (Q3) সময়ের অনিরীক্ষিত আর্থিক বিবরণী বিবেচনার জন্য 27 এপ্রিল, 2026 তারিখে বিকাল 3:00 টায় পরিচালক পর্ষদের একটি সভা অনুষ্ঠিত হবে।
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 69e70edcb322cf5e51d4a067
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from BEACONPHAR
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.